CYPROTEX

Serial Number 79291031
Registration 6375243
700

Registration Progress

Application Filed
May 28, 2020
Under Examination
Approved for Publication
Mar 23, 2021
Published for Opposition
Mar 23, 2021
Registered
Jun 8, 2021

Trademark Image

CYPROTEX

Basic Information

Serial Number
79291031
Registration Number
6375243
Filing Date
May 28, 2020
Registration Date
June 8, 2021
Published for Opposition
March 23, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 8, 2021
Registration
Registered
Classes
042

Rights Holder

Cyprotex Discovery Limited

99
Address
No.24 Mereside, Alderley Park,
Nether, Alderley Cheshire SK10 4TG
GB

Ownership History

Cyprotex Discovery Limited

Original Applicant
99
GB

Cyprotex Discovery Limited

Owner at Publication
99
GB

Cyprotex Discovery Limited

Original Registrant
99
GB

Legal Representation

Attorney
William E O'Brien Esq.

USPTO Deadlines

Next Deadline
531 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20210608)
Due Date
June 08, 2027
Grace Period Ends
December 08, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Nov 6, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 25, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 28, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 28, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 8, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 8, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 23, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 23, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 22, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Mar 3, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Mar 3, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Mar 3, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 12, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 12, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 12, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 12, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 12, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 12, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 12, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 12, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 19, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Sep 28, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Sep 28, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Sep 8, 2020 CNRT F NON-FINAL ACTION MAILED Loading...
Sep 7, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Sep 6, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 6, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 6, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 6, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 28, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 11, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Aug 7, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 6, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development; contract research organization services (CRO) for pharmaceutical, biotechnology, agrochemical and chemical industries, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes and research and development of new products; screening of chemical compounds being testing of chemicals; testing of chemical compounds; absorption, distribution, metabolism, excretion and toxicology testing of chemical compounds; data analysis of pharmacokinetic properties being testing of pharmaceuticals; computer based predictive methods, namely, testing of pharmaceuticals; provision of scientific information in the field pharmacokinetics; molecular and physiological mathematical modelling being computer modeling services

Classification

International Classes
042